Physician Assistant, Medical · Jackson, MS
NPI
1447965108
Since 2023
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2500 N State St
Jackson, MS, 39216
Phone (601) 622-5691
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
304 services
Medicare patients, 2024
171
Average age 62
Drug cost, 2024
$10.5M
2,135 prescriptions
Company payments, 2025
$1,458
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew D McCoy was code 99214 (office e&m - established), 117 times for 83 patients. In total Matthew D McCoy billed 304 services in 7 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 117 | 83 | $54.34 | $6,358 |
| 99213 Office E&M - Established | Facility | 56 | 51 | $39.58 | $2,216 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 53 | 41 | $9.92 | $526 |
| 99204 Office E&M - New | Facility | 29 | 29 | $65.83 | $1,909 |
| 99215 Office E&M - Established | Facility | 28 | 23 | $86.39 | $2,419 |
| 99203 Office E&M - New | Facility | 19 | 19 | $48.38 | $919 |
By year: 2023 $12K for 183 services; 2024 $15K for 304 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew D McCoy prescribed most often to Medicare patients was Stelara (Ustekinumab), with 192 prescriptions and refills. In total Matthew D McCoy wrote 2,135 Medicare prescriptions that cost $10.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stelara Ustekinumab | 192 | 250 | 26 | $5.3M |
| Famotidine Generic | 181 | 390 | 60 | $2,132 |
| Omeprazole Generic | 144 | 334 | 55 | $1,723 |
| Sodium Chloride 0.9 % Sodium Chloride | 126 | 126 | Under 11 | $698 |
| Pantoprazole Sodium Generic | 113 | 243 | 44 | $1,782 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 89 | 91 | 21 | $3,536 |
| Rinvoq Upadacitinib | 83 | 94 | 11 | $837K |
| Ondansetron Odt Ondansetron | 70 | 70 | 26 | $731 |
| Loperamide Loperamide Hcl | 70 | 73 | 18 | $2,273 |
| Gattex Teduglutide | 63 | 63 | Under 11 | $2.8M |
| Tacrolimus Generic | 62 | 97 | 15 | $8,243 |
| Magnesium Sulfate Generic | 51 | 51 | Under 11 | $118 |
| Promethazine Hcl Generic | 51 | 51 | 18 | $384 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 46 | 46 | 46 | $1,135 |
| Linzess Linaclotide | 43 | 77 | 18 | $39K |
Brand drugs: 805 claims; generic drugs: 1,330 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew D McCoy $1,458 ($1,458 in general payments such as food, travel and fees) from 13 companies. The largest payer was Janssen Biotech, Inc. with $512.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 13 | $512 |
| Abbvie Inc. ABBV | 8 | $256 |
| Janssen Scientific Affairs, LLC JNJ | 2 | $182 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $159 |
| Madrigal Pharmaceuticals MDGL | 5 | $108 |
| Aimmune Therapeutics, Inc. | 4 | $70.2 |
| Ardelyx, Inc. ARDX | 2 | $41.55 |
| Mallinckrodt Hospital Products Inc. | 1 | $31.32 |
| Pfizer Inc. PFE | 1 | $29.04 |
| QOL Medical, LLC | 1 | $22.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.